Provided by Tiger Trade Technology Pte. Ltd.

HBM HOLDINGS-B

13.180
-1.010-7.12%
Volume:5.32M
Turnover:72.66M
Market Cap:11.45B
PE:119.82
High:14.010
Open:14.000
Low:13.150
Close:14.190
52wk High:17.070
52wk Low:9.460
Shares:869.00M
HK Float Shares:869.00M
Volume Ratio:1.28
T/O Rate:0.61%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.110
ROE:23.97%
ROA:10.88%
PB:3.50
PE(LYR):119.82
PS:8.15

Loading ...

HBM HOLDINGS-B (02142) Grants 103,000 Share Awards

Stock News
·
Mar 31

Stock Track | HBM HOLDINGS-B Soars 5.28% Intraday on Strong 2025 Financial Results with Revenue Tripling and Profit Surging 33-Fold

Stock Track
·
Mar 31

HBM HOLDINGS-B (02142) Reports 2025 Financial Results with USD 92.22 Million After-Tax Profit, Surging Approximately 32.63-Fold

Stock News
·
Mar 30

Hbm Holdings - FY Profit US$92.2 Mln

THOMSON REUTERS
·
Mar 30

HBM FY25 profit jumps to US$ 92 million; revenue more than tripled to US$ 160 million

Reuters
·
Mar 30

Press Release: Harbour BioMed Reports Full Year 2025 Financial Results: Sustained Global Collaboration Underpins Long-Term Growth

Dow Jones
·
Mar 30

HBM Holdings (SEHK:2142) Valuation After Positive HBM9378 Trial Data And New Regulatory And Licensing Progress

Simply Wall St.
·
Mar 28

Hong Kong Stocks Surge as TSLP Antibody Therapy Phase I Trial Results Published

Stock News
·
Mar 24

Harbour BioMed publishes Phase I results for TSLP antibody HBM9378 in 50 healthy adults

Reuters
·
Mar 23

Harbour BioMed appoints Jenny Xie as chief scientific officer for immunology

Reuters
·
Mar 19

Harbour Biomed Appoints DR. Jenny Xie as Chief Scientific Officer, Immunology and Head of Global External Innovation

THOMSON REUTERS
·
Mar 19

HBM Holdings-B (02142) Schedules 30 March 2026 Board Meeting to Approve FY 2025 Results

Bulletin Express
·
Mar 18

HBM Holdings schedules board meeting to approve annual results for 2025

Reuters
·
Mar 18

HBM HOLDINGS-B Sees Shares Plunge Over 40% in 5 Months: Is BD Good News a "Sell Signal"?

Stock News
·
Mar 15